Less ‘harm’ from lung cancer screening than trials suggested 

The ‘harms’ of screening for lung cancer such as overdiagnosis are much lower in real-world implementation than were suggested in large RCTs, UK researchers report. Presenting combined real-world data from five UK pilot sites at the 2020 World Conference on Lung Cancer, researchers reported an overall lung cancer detection rate of 2.1%. The analysis of ...